MedTrace Logo

Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain

NCT03910296 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2022-05-03

No results posted yet for this study

Summary

The purpose of this research study is to develop a psychological treatment for patients with cancer, focused on the psychological symptoms they experience during opioid therapy.

Conditions

Interventions

BEHAVIORAL

Acceptance & Commitment Therapy

ACT is a unique, third-wave therapy that uses metaphors and experiential exercises to encourage contact with previously avoided thoughts, feelings, and behaviors.

Sponsors & Collaborators

Principal Investigators

  • Miryam Yusufov, MD · Dana-Farber Cancer Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-20
Primary Completion
2021-06-30
Completion
2021-07-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03910296 on ClinicalTrials.gov